AU2003301397A1 - Transdermal patch for external use comprising fentanyl - Google Patents

Transdermal patch for external use comprising fentanyl

Info

Publication number
AU2003301397A1
AU2003301397A1 AU2003301397A AU2003301397A AU2003301397A1 AU 2003301397 A1 AU2003301397 A1 AU 2003301397A1 AU 2003301397 A AU2003301397 A AU 2003301397A AU 2003301397 A AU2003301397 A AU 2003301397A AU 2003301397 A1 AU2003301397 A1 AU 2003301397A1
Authority
AU
Australia
Prior art keywords
fentanyl
transdermal patch
external use
transdermal
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003301397A
Other languages
English (en)
Inventor
Naruhito Higo
Ken Ito
Tetsuro Tateishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32105147&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2003301397(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of AU2003301397A1 publication Critical patent/AU2003301397A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003301397A 2002-10-18 2003-10-17 Transdermal patch for external use comprising fentanyl Abandoned AU2003301397A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-304914 2002-10-18
JP2002304914 2002-10-18
PCT/JP2003/013292 WO2004035054A1 (ja) 2002-10-18 2003-10-17 フェンタニル経皮外用貼付剤

Publications (1)

Publication Number Publication Date
AU2003301397A1 true AU2003301397A1 (en) 2004-05-04

Family

ID=32105147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003301397A Abandoned AU2003301397A1 (en) 2002-10-18 2003-10-17 Transdermal patch for external use comprising fentanyl

Country Status (10)

Country Link
US (1) US7718188B2 (ko)
EP (1) EP1552835B1 (ko)
JP (1) JP4542429B2 (ko)
KR (1) KR100995696B1 (ko)
CN (1) CN1298326C (ko)
AU (1) AU2003301397A1 (ko)
CA (1) CA2502220C (ko)
ES (1) ES2386891T3 (ko)
TW (1) TWI296531B (ko)
WO (1) WO2004035054A1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DK1381352T3 (da) * 2001-03-16 2007-07-09 Alza Corp Plaster til transdermal indgivelse af fentanyl
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
JP4824963B2 (ja) 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
PL1814531T3 (pl) * 2004-10-21 2010-11-30 Durect Corp Transdermalne systemy dostarczania
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
WO2007023791A1 (ja) * 2005-08-22 2007-03-01 Hisamitsu Pharmaceutical Co., Inc. 外用剤
CN101454007B (zh) * 2006-07-14 2011-04-13 久光制药株式会社 贴剂
CN101902996B (zh) * 2007-10-15 2014-11-26 阿尔扎公司 芬太尼的一天更换一次透皮施用
JP5535640B2 (ja) * 2007-10-17 2014-07-02 久光製薬株式会社 フェンタニル含有経皮吸収製剤
JP5431969B2 (ja) * 2008-01-28 2014-03-05 帝國製薬株式会社 フェンタニル含有外用貼付剤
KR20090101579A (ko) * 2008-03-24 2009-09-29 조선대학교산학협력단 펜타닐을 함유한 경피 흡수제
EP2268244B1 (en) 2008-03-31 2018-07-04 Nitto Denko Corporation Permeant delivery system and methods for use thereof
EP2111857A1 (de) 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
TWI541246B (zh) 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡
EP2295046B1 (de) 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
US20110200663A1 (en) * 2010-02-12 2011-08-18 Nitto Denko Corporation Methylphenidate patch preparation
US9055745B2 (en) 2011-04-13 2015-06-16 Natureza, Inc. Compositions for internal and external insecticides, ovicides, repellents and wound healing
EP2599478A1 (de) * 2011-11-30 2013-06-05 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
US9072682B2 (en) 2012-12-31 2015-07-07 Mylan Inc. Transdermal dosage form for low-melting point active agent
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
CN105451911B (zh) 2013-06-13 2018-10-12 微德米克斯公司 金属微针
EP3700511A1 (en) 2017-10-17 2020-09-02 Lubrizol Advanced Materials, Inc. Composition and device for delivery of active agents to skin surfaces

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5508038A (en) 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
JP2869167B2 (ja) 1990-08-09 1999-03-10 日東電工株式会社 徐放性貼付製剤
JPH07206710A (ja) * 1994-01-21 1995-08-08 Nitto Denko Corp 経皮投薬用テープ製剤
US5635204A (en) 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
DE69526437T2 (de) 1994-05-18 2002-10-31 Hisamitsu Pharmaceutical Co Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
JP3836566B2 (ja) 1996-05-13 2006-10-25 久光製薬株式会社 フェンタニル含有経皮投与テープ製剤
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
JP3943724B2 (ja) 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
CN1235572C (zh) 1999-12-15 2006-01-11 久光制药株式会社 贴剂
GB0008328D0 (en) * 2000-04-06 2000-05-24 Adv Med Solutions Ltd Pressure sensitive adhesive compositions
DK1381352T3 (da) 2001-03-16 2007-07-09 Alza Corp Plaster til transdermal indgivelse af fentanyl

Also Published As

Publication number Publication date
TW200413034A (en) 2004-08-01
KR100995696B1 (ko) 2010-11-19
CN1705482A (zh) 2005-12-07
CA2502220C (en) 2011-03-15
JPWO2004035054A1 (ja) 2006-02-09
CA2502220A1 (en) 2004-04-29
EP1552835A4 (en) 2011-03-16
JP4542429B2 (ja) 2010-09-15
US7718188B2 (en) 2010-05-18
EP1552835B1 (en) 2012-06-13
KR20050062627A (ko) 2005-06-23
US20060013865A1 (en) 2006-01-19
TWI296531B (en) 2008-05-11
EP1552835A1 (en) 2005-07-13
CN1298326C (zh) 2007-02-07
ES2386891T3 (es) 2012-09-05
WO2004035054A1 (ja) 2004-04-29

Similar Documents

Publication Publication Date Title
AU2003301397A1 (en) Transdermal patch for external use comprising fentanyl
IL243302A0 (en) Patch to stick on skin for fentanyl administration
AU2003299034A1 (en) Transdermal compositions
HK1086026A1 (en) Adhesive patch for external use on skin
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003299189A1 (en) Patch
AU2003277306A1 (en) Microneedle array patch
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
AU2003221770A1 (en) Controlled release transdermal drug delivery
AU2003221354A1 (en) Sheet-type patch
AU2003266267A1 (en) Birefringent marking
AU2003268014A1 (en) Sallistic protection apparatus
AU2003249683A1 (en) Nf-:b inhibitors
AU2003242218A1 (en) Patch
AU2003253176A1 (en) Monocyclic derivatives as matrix metalloproteinase inhibitors
AU2003233357A1 (en) Dressing aid
AU2002316480A1 (en) Tissue tensioning electrotherapy device
AU2003228198A1 (en) Av-fistula bandage
AU2003202491A1 (en) Electrode device for iontoforesis
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
HK1176880A1 (en) Norethisterone-containing patch
AU2003255708A1 (en) Restricting device
AU2003252337A1 (en) Patch for transdermal administration
AUPS317102A0 (en) Transdermal aerosol compositions
AU2002329530A1 (en) Transdermal delivery system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase